Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Alimera Sciences Limited is a pharmaceutical company that specialises in the commercialisation and development of prescription ophthalmic pharmaceuticals. It was founded in 2003 and is currently focused on diseases affecting the posterior segment of the eye. For more information, please visit www.alimerasciences.eu
As a leader in eye care, Allergan has discovered, developed, and delivered some of the most innovative products in the industry for more than 70 years. Allergan has launched over 125 eye care products and invested billions of dollars in new treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion. Our eye care pipeline includes over a dozen additional agents for multiple ocular conditions. We remain steadfast in helping eye care providers deliver the best in patient care through innovative products and outreach programs.
Apellis is a global biopharmaceutical company that combines courageous science, creativity, and compassion to deliver life-changing medicines. We are exploring the potential of targeting C3, the central protein of the complement system. Intravitreal pegcetacoplan, an investigational targeted C3 therapy has the potential to be the first approved treatment for geographic atrophy (GA). Recently, we announced the completed enrollment DERBY and OAKS, two phase 3 studies investigating intravitreal pegcetacoplan in GA secondary to age-related macular degeneration. People living with GA need a treatment and we believe that pegcetacoplan has the potential to control the excessive complement activation that drives GA.
With over 166 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and eye surgery. Our Surgical Division provides a complete product portfolio for Cataract, Refractive, Corneal and Retinal surgery.] new[With over 166 years of innovation, Bausch+Lomb is a leading global eye care brand with expertise in contact lenses and lens care, pharmaceuticals and surgery. The Surgical Division provides a complete product portfolio for cataract, refractive, corneal and retinal surgery. This includes our combined Stellaris Elite™ system, designed to deliver optimized control and efficiency to a wide range for cataract and retinal procedures, the BiBlade® vitrectomy cutter with its dual port design and our Vitesse® hypersonic vitrectomy system for a new approach to vitreous removal. Combined with our comprehensive instrument range, we provide for individual surgeon techniques and patient needs.
Bayer in ophthalmology aims to reduce the number of people impacted by visual impairment through innovation. Bayer is committed to addressing unmet needs, including identifying ways to minimize the treatment burden, increase treatment effectiveness and discover new eye therapies. Bayer offers a recognized treatment for various retinal diseases, such as neovascular (wet) age-related macular degeneration, diabetic macular edema and retinal vein occlusion. PP-EYL-ALL-0664-1
Beyeonics Surgical is a medical technology company developing surgeon-centered visualization solutions. Beyeonics brings the pilots Augmented Reality experience into the world of surgery – leverages cutting-edge fighter pilots head mounted display technologies to provide surgeons with outstanding visualization, exceptional comfort, streamlined information access and optimized surgical workflow. Beyeonics One™ visualization Platform, our digital microscope redefines the standard for operating room (OR) visualization. Beyeonics One™ serves as a digital extension of the surgeon, providing augmented reality vision and allows integration of data in real time.]
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Biogen has a portfolio of medicines to treat certain types of multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, commercializes biosimilars, and is focused on advancing neuroscience research programs in Alzheimer’s disease and dementia, multiple sclerosis and neuroimmunology, movement disorders, neuromuscular disorders, pain, ophthalmology, neuropsychiatry and acute neurology. To learn more, please visit www.biogen.com
Family-owned since it was established in 1885, Boehringer Ingelheim has expanded its global research and development activities to tackle eye diseases, specifically those affecting the back of the eye. Driven by our passion to improve care, we will transform the retinal health landscape by developing novel treatments and technologies, especially where nothing currently exists. Our ambition is clear – prevent vision loss in people at risk and preserve or restore vision in those with retinal diseases. We have a pioneering approach to innovation that will help people with eye diseases live a brighter future.
BTI Biotechnology Institute S.L. Spain Endoret® (PRGF®) for Ophthalmology Autologous blood derived technology for ocular tissue regeneration Eye drops and fibrin matrix
BVI® is a ophthalmic medical device manufacturer with a mission to deliver high quality solutions and innovation for advancing eye surgery and improving the vision of patients. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams, in more than 115 countries worldwide, either directly or through our network of trusted distributors. Our trusted brands include: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium Intraocular Lenses).
Quantel Medical & Ellex united since July 2020 to develop innovative imaging & therapeutic solutions
EURETINA is a non-profit organization also known as the European Society of Retina Specialists. The aims of EURETINA are:
• To establish personal contacts and to promote the exchange of knowledge between vitreoretinal and macula specialists in Europe.
• To stimulate and encourage vitreoretinal and macula research in Europe.
• To promote the diffusion of specific knowledge to general ophthalmologists in Europe.
• To keep contact with similar groups in other continents.
These aims are realized through the organization of annual scientific congresses, which offer members of the Society a forum for the exchange of ideas.
At Roche, our innovative clinical programmes focus on some of the main causes of blindness and visual impairment globally, aiming to advance science and improve care for people living with retinal conditions. Our work in ophthalmology is driven by our commitment to make a real difference to people with vision loss, their families and caregivers, building on our legacy of pioneering breakthrough therapies for those who need them.
FCI is a global, multi-site company with its headquarter in Paris, France, a branch FCI Ophthalmics in Boston, MA (USA) managing our North American operations, and a strong distribution network that serves more than 80 countries. Our core business and activities involve extensive research & development and advanced manufacturing processes to enhance the effectiveness and performance of the procedures performed by our customers. Your Patients, Our Expertise.
The International Fight Retinal Blindness! (FRB!) Project is an outcomes registry that allows clinicians to track, analyse and report data on “real world” treatment outcomes of some of the major causes of visual impairment, creating a resource that can ensure the best possible patient outcomes worldwide. There are several different modules available within the project including Fight Glaucoma Blindness, Fight Corneal Blindness and Fight Tumour Blindness. Come and speak to our team about joining FRB! today.
Geuder AG is a leading German manufacturer of ophthalmic surgical instruments and systems as well as provider for highly purified biomaterials. The broad portfolio of 3.000 products distributed in more than 100 countries includes a wide range of surgical equipment for the anterior and posterior segments of the eye, along with highly innovative biomaterials for retinal and cataract surgery developed and produced by our affiliated company Fluoron GmbH. We are always keeping our goal to provide the highest level of quality, precision and reliability while complying with regulatory and surgeons’ requirements to serve the patient’s expectations and well-being.
Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits. Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand. The growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and data mining.
Founded in 2003, Horus Pharma laboratory has become a key player in ophthalmology in France and Europe. Horus Pharma combines the flexibility and environment of a French family business, with an international expansion and continuous growth for more than 10 years. Our goal is to be a generalist innovative company: through differentiated products and services for healthcare professionals and their patients, such as augmented reality.
Karger Publishers is a worldwide publisher of scientific and medical content based in Basel, Switzerland. It is independent and family-led in the fourth generation by Chairwoman and Publisher Gabriella Karger. Karger has been continuously evolving, keeping pace with the current developments and shifts in research and publishing. The publishing house is dedicated to serving the information needs of the scientific community, clinicians and patients with publications of high-quality content and services in health sciences.
LumiThera is committed to creating a brighter horizon for patients by developing treatment solutions utilizing Photobiomodulation to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness. The Valeda Light Delivery System is the first approved treatment for Dry Age-Related Macular Degeneration using Photobiomodulation. Valeda improves visual acuity, improves contrast sensitivity, reduces central drusen volume, and is designed for ease of use in the clinician’s office. The Valeda Light Delivery System is CE Marked. Valeda is not approved for use in the United States. Visit www.lumithera.com to learn more.
Media MICE is not your average ophthalmic media company. This Singapore-based medical publishing and marketing company produces content that is well-researched and well-written, in a style that is decidedly different in the ophthalmic world. Our magazine brands, PIE (Posterior Segment – Innovation – Enlightenment) and CAKE (Cataract – Anterior Segment – Kudos – Enlightenment), reveal this difference. We specialize in digital marketing, medical writing and publishing. We do advertising, sponsored articles, global symposium coverage, marketing campaigns, product launch support, photoshoots, videos, congress show-dailies, custom newsletters, social media marketing, interactive content including creative digital booths/events, and other medical editorial and marketing.
NIDEK provides a comprehensive portfolio of ophthalmic, optometric and opticianry products. Through the special contents limited for EURETINA/ESCRS, we introduce our innovative products such as Mirante, a Multimodal Imaging OCT/SLO Combo Platform. Please visit our booth.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at. www.novartis.com
OCULUS, the inventor of the SDI®/BIOM® system – the first non-contact wide angle viewing system for vitreoretinal surgery – set up the department “OCULUS Surgical” to improve care of its exclusive circle of customers – ophthalmic surgeons. The product range of the SDI®/BIOM® system is constantly expanding: Check out the BIOM® ready, the world’s first disposable wide angle viewing system and even more disposable options. Do you know the HD Disposable LenZ for the ZEISS system? You can benefit from the OCULUS quality even if you don’t use the BIOM® system. We have more solutions for you: get in touch.
OD-OS is the global leader in the development and commercialization of navigated laser photocoagulators for Ophthalmology. OD-OS’ compact Navilas® Laser System 577s enables physicians to digitally pre-plan the entire laser therapy on fundus images as well as external diagnostic images and precisely execute this therapy plan under computer guidance. Unlike any other retina laser, Navilas offers focal treatments without a contact lens and infrared illumination for unsurpassed patient comfort. A large field of view and assisted pattern positioning greatly improve speed in panretinal and focal treatments.
OERTLI® – MAKING THE DIFFERENCE IN EYE SURGERY. Oertli develops, manufactures and distributes surgical platforms, instruments and consumables with which surgeons and OR personnel can work easier, safer and more efficient and thus achieve better results for the patient. Our lasting innovations since 1955 and new technologies have a long-term impact on cataract, glaucoma and vitreoretinal surgeries. Please visit our virtual booth to explore our latest innovations for vitreoretinal surgeries!
Only Optos can produce 200° single-capture ultra-widefield retinal images in less than ½ second. Over 1,000 peer-reviewed studies show the value of our high-resolution optomap® images in the early detection, management and treatment of retinal disorders and diseases. Customers who invest in Optos differentiate themselves from competitors, enhance their reputation, delight customers and build additional revenue.
Orbis is an international eye care charity that prevents and treats avoidable blindness and visual impairment. Of the 253 million people in the world who are blind or visually impaired, 75% have conditions that are preventable or treatable. We screen for and treat eye conditions, raise awareness about eye health, and train and mentor local eye care teams in Africa, Asia and Latin America, where most of those people live. We do this through our long-term programmes as well as on the Orbis Flying Eye Hospital, a state-of-the-art ophthalmic teaching hospital on board a customised aircraft.
Quantel Medical & Ellex united since July 2020 to develop innovative imaging & therapeutic solutions
Topcon Healthcare: advanced imaging and data technology for diagnostic confidence.
Carl Zeiss Meditec AG offers complete solutions, including implants and consumables, to diagnose and treat eye conditions and ophthalmic diseases. The comprehensive ZEISS portfolio is designed to meet the demands of eye care professionals and help them deal with an increasingly challenging healthcare environment.